Found: 49
Select item for more details and to access through your institution.
Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 10, p. 2055, doi. 10.1002/ejhf.3340
- By:
- Publication type:
- Article
Evaluation of left atrial remodeling using cardiovascular magnetic resonance imaging in breast cancer patients treated with adjuvant trastuzumab.
- Published in:
- European Radiology, 2022, v. 32, n. 6, p. 4234, doi. 10.1007/s00330-021-08466-9
- By:
- Publication type:
- Article
Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis.
- Published in:
- Systematic Reviews, 2018, v. 7, n. 1, p. N.PAG, doi. 10.1186/s13643-018-0854-y
- By:
- Publication type:
- Article
Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis.
- Published in:
- Systematic Reviews, 2017, v. 6, p. 1, doi. 10.1186/s13643-017-0588-2
- By:
- Publication type:
- Article
A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 807, doi. 10.1007/s10549-020-05976-w
- By:
- Publication type:
- Article
A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 2, p. 507, doi. 10.1007/s10549-020-05960-4
- By:
- Publication type:
- Article
Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231175440
- By:
- Publication type:
- Article
Intravenous iron and iron deficiency anemia in patients with gastrointestinal cancer: A systematic review.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0302964
- By:
- Publication type:
- Article
Gynecologic Symptoms among Hormone Receptor-Positive Breast Cancer Patients on Oral Endocrine Therapy: A Cross-Sectional Study.
- Published in:
- Current Oncology, 2022, v. 29, n. 3, p. 1813, doi. 10.3390/curroncol29030149
- By:
- Publication type:
- Article
Evaluation of Adjuvant Chemotherapy-Associated Steatosis (CAS) in Colorectal Cancer.
- Published in:
- Current Oncology, 2021, v. 28, n. 4, p. 3030, doi. 10.3390/curroncol28040265
- By:
- Publication type:
- Article
Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma - significance of potentially retained stemness.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A multicentre, open-label phase II study of Irinotecan, capecitabine (Xeloda®), and Oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 674, doi. 10.1007/s10637-018-0599-4
- By:
- Publication type:
- Article
Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359211066677
- By:
- Publication type:
- Article
Positive progress: current and evolving role of immune checkpoint inhibitors in metastatic triple-negative breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920909091
- By:
- Publication type:
- Article
Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12558-2
- By:
- Publication type:
- Article
Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 157, n. 3, p. 535, doi. 10.1007/s10549-016-3823-y
- By:
- Publication type:
- Article
Is knowledge translation adequate? A quality assurance study of staging investigations in early stage breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 132, n. 1, p. 1, doi. 10.1007/s10549-011-1786-6
- By:
- Publication type:
- Article
Autoimmune hypothyroidism and breast cancer in the elderly.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 115, n. 3, p. 635, doi. 10.1007/s10549-008-0104-4
- By:
- Publication type:
- Article
A population‐based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with triple‐negative breast cancer.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 20, p. 7548, doi. 10.1002/cam4.3038
- By:
- Publication type:
- Article
Nonoperative management protocol for locally advanced rectal cancer.
- Published in:
- Colorectal Disease, 2024, v. 26, n. 6, p. 1285, doi. 10.1111/codi.17035
- By:
- Publication type:
- Article
Autophagic Heterogeneity in Gastric Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.555614
- By:
- Publication type:
- Article
Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 12, p. 1, doi. 10.1371/journal.pone.0224812
- By:
- Publication type:
- Article
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1945, doi. 10.1002/ejhf.1920
- By:
- Publication type:
- Article
Clinicians' Perspectives on Barriers to Discussing Infertility and Fertility Preservation With Young Women With Cancer.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 11, p. e1914511, doi. 10.1001/jamanetworkopen.2019.14511
- By:
- Publication type:
- Article
Trends and Prescriber Variation in the Duration of Oxaliplatin-Containing Adjuvant Chemotherapy for Stage III Colon Cancer From 2007 to 2019: A Population-Based Retrospective Cohort Study.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 4, p. 431, doi. 10.1016/j.clcc.2023.08.003
- By:
- Publication type:
- Article
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Intestinal Metaplasia and the Risk of Gastric Cancer in an Immigrant Asian Population.
- Published in:
- Clinical Medicine Insights: Gastroenterology, 2012, n. 5, p. 43, doi. 10.4137/CGast.S10070
- By:
- Publication type:
- Article
Assessment of left ventricular function by CMR versus MUGA scans in breast cancer patients receiving trastuzumab: a prospective observational study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
HERStory: The Next Chapter in HER-2-Directed Therapy for Advanced Breast Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 11, p. 1153, doi. 10.1634/theoncologist.2013-0217
- By:
- Publication type:
- Article
Cancer and Cardiovascular Disease: The Complex Labyrinth.
- Published in:
- Journal of Oncology, 2015, v. 2015, p. 1, doi. 10.1155/2015/516450
- By:
- Publication type:
- Article
Mammographic microcalcifications and breast cancer tumorigenesis: a radiologic-pathologic analysis.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1312-z
- By:
- Publication type:
- Article
The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comprehensive genomic profiling for oncological advancements by precision medicine.
- Published in:
- Medical Oncology, 2024, v. 41, n. 1, p. 1, doi. 10.1007/s12032-023-02228-x
- By:
- Publication type:
- Article
Incidence and identification of risk factors for trastuzumab-induced cardiotoxicity in breast cancer patients: an audit of a single "real-world" setting.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer.
- Published in:
- Current Oncology, 2024, v. 31, n. 9, p. 5694, doi. 10.3390/curroncol31090422
- By:
- Publication type:
- Article
Best Practices for Managing Patients with Unresectable Metastatic Gastric and Gastroesophageal Junction Cancer in Canada.
- Published in:
- Current Oncology, 2024, v. 31, n. 5, p. 2552, doi. 10.3390/curroncol31050191
- By:
- Publication type:
- Article
Real-World Treatment Patterns and Clinical Outcomes among Patients Receiving CDK4/6 Inhibitors for Metastatic Breast Cancer in a Canadian Setting Using AI-Extracted Data.
- Published in:
- Current Oncology, 2024, v. 31, n. 4, p. 2172, doi. 10.3390/curroncol31040161
- By:
- Publication type:
- Article
The Canadian Breast Cancer Symposium 2023 Meeting Report.
- Published in:
- Current Oncology, 2024, v. 31, n. 4, p. 1774, doi. 10.3390/curroncol31040135
- By:
- Publication type:
- Article
Barriers and Unequal Access to Timely Molecular Testing Results: Addressing the Inequities in Cancer Care Delays across Canada.
- Published in:
- Current Oncology, 2024, v. 31, n. 3, p. 1359, doi. 10.3390/curroncol31030103
- By:
- Publication type:
- Article
Iron Surveillance and Management in Gastro-Intestinal Oncology Patients: A National Physician Survey †.
- Published in:
- Current Oncology, 2023, v. 30, n. 11, p. 9836, doi. 10.3390/curroncol30110714
- By:
- Publication type:
- Article
Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective.
- Published in:
- Current Oncology, 2023, v. 30, n. 9, p. 8019, doi. 10.3390/curroncol30090582
- By:
- Publication type:
- Article
The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based Retrospective Cohort Study.
- Published in:
- Current Oncology, 2023, v. 30, n. 7, p. 6508, doi. 10.3390/curroncol30070478
- By:
- Publication type:
- Article
HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review.
- Published in:
- Current Oncology, 2023, v. 30, n. 6, p. 5425, doi. 10.3390/curroncol30060411
- By:
- Publication type:
- Article
Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29 , 9891–9895"
- Published in:
- Current Oncology, 2023, v. 30, n. 5, p. 5050, doi. 10.3390/curroncol30050381
- By:
- Publication type:
- Article
Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain.
- Published in:
- Current Oncology, 2022, v. 29, n. 12, p. 9891, doi. 10.3390/curroncol29120778
- By:
- Publication type:
- Article
Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian Perspective.
- Published in:
- Current Oncology, 2022, v. 29, n. 4, p. 2720, doi. 10.3390/curroncol29040222
- By:
- Publication type:
- Article
Prognostic significance of human tissue kallikrein-related peptidases 6 and 10 in gastric cancer.
- Published in:
- Biological Chemistry, 2014, v. 395, n. 9, p. 1087, doi. 10.1515/hsz-2014-0143
- By:
- Publication type:
- Article